|
Sign In to gain access to subscriptions and/or personal tools.
|
Nutrition in Clinical Practice, Vol. 20, No. 1,
62-74 (2005)
DOI: 10.1177/011542650502000162
© 2005 The American Society for Parenteral and Enteral Nutrition
Experimental Studies Defining -3 Fatty Acid Antiinflammatory Mechanisms and Abrogation of Tumor-Related Syndromes
Tricia A. Babcock, MS*,
Thomas Dekoj, BS* and
N. Joseph Espat, MD, MS, FACS
* Department of Surgery and
Departments of Surgery and Pharmacology,
University of Illinois at Chicago
Correspondence: N. Joseph Espat, MD, MS, FACS, Associate Professor of Surgery,
University of Illinois at Chicago, Department of Surgery M/C 958, 840 S. Wood
St., Room 435E, Chicago, IL 60612. Electronic mail may be sent to
jespat{at}uic.edu.
Clinical and experimental evidence has supported a benefit for the
inclusion of fish oils (a primary source of -3 fatty acids) as a
component of a normal healthy diet. Polyunsaturated -3 fatty acids have
been demonstrated to be of benefit in a number of inflammation-associated
disease states, including atherosclerosis, autoimmune disorders, malignancy,
and sepsis. The beneficial effects of -3 fatty acids are thought to
occur through the postulated antiinflammatory actions of -3 fats;
however, the specific mechanism(s) of action has not been completely defined.
In this review, we discuss the recent progress made in our laboratory on
defining the mechanisms of -3 fatty acids activity.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
R. Siddiqui, D. Pandya, K. Harvey, and G. P. Zaloga
Nutrition Modulation of Cachexia/Proteolysis
Nutr Clin Pract,
April 1, 2006;
21(2):
155 - 167.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|